CLINICAL_TRIALS
trial_result
· 2017-08-24
Clinical Trial Update: A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression [Phase 3]
Summary
Phase 3 trial investigating olanzapine and fluoxetine for treatment-resistant depression has been terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Treatment Resistant Depression | Phase 3 | Status: TERMINATED | Results posted: 2017-08-24